Targeted investigations into the impact of ABCC8 and TRPM4 genetic variation on cerebral edema, intracranial hypertension, and outcome after TBI have been performed in 385–485 patients with severe TBI from a single-center [28,122,123,124]. The gene discussed is TRPM4; the disease is intracranial hypertension.